data_1wqb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wqb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.22 0.533 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.468 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 ' C ' ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.517 ' ND1' ' CB ' ' A' ' 25' ' ' ASP . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.437 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.181 0.515 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' PRO . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 22' ' ' LEU . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' HD21 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.538 ' CD1' ' C ' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' CB ' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 51.5 m-70 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HA ' HD23 ' A' ' 22' ' ' LEU . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.409 0.624 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.572 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 20.3 m-70 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.356 0.598 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.482 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD21 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.528 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.537 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.189 0.519 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.513 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 31' ' ' PRO . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.564 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 9.0 m170 -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' HD22 ' A' ' 22' ' ' LEU . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.318 0.58 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 19' ' ' CYS . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' O ' HD21 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 21' ' ' GLY . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 17.2 m-70 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 31' ' ' PRO . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.479 0.657 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HA ' ' HB1' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 38.4 m-70 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 18' ' ' CYS . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.578 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.578 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HA ' ' HB1' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 18' ' ' CYS . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.8 m-70 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.413 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.079 0.466 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 18' ' ' CYS . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.46 ' O ' ' HB1' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CG ' ' CD2' ' A' ' 30' ' ' HIS . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.553 ' CD2' ' CG ' ' A' ' 25' ' ' ASP . 3.1 m-70 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HA ' HD23 ' A' ' 22' ' ' LEU . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.418 ' HG3' ' NH2' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' O ' ' HB1' ' A' ' 5' ' ' ALA . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.565 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' CB ' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.427 ' HB1' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' CYS . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 7' ' ' VAL . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.299 0.571 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 22' ' ' LEU . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.463 ' O ' HD22 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.28 0.562 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.54 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 14.0 m-70 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD2' ' CB ' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.489 ' CB ' ' OD2' ' A' ' 25' ' ' ASP . 4.1 m170 -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m95 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.265 0.555 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.34 -58.21 1.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.01 -112.53 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p -151.52 175.01 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.468 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.429 ' C ' ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.517 ' ND1' ' CB ' ' A' ' 25' ' ' ASP . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.231 0.539 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.52 124.07 35.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.94 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.59 6.1 5.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.21 -163.19 0.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 109.876 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' PRO . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 22' ' ' LEU . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' HD21 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 3' ' ' GLY . 63.1 m95 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.357 0.599 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.0 mt 50.06 -93.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 1' ' ' TRP . . . -174.13 115.92 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p -149.43 145.77 27.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -1.168 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.538 ' CD1' ' C ' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' CB ' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 51.5 m-70 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HA ' HD23 ' A' ' 22' ' ' LEU . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.52 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.59 -18.15 0.88 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p -104.3 -152.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.251 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.572 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 20.3 m-70 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.267 0.556 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.2 mt -114.76 131.52 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 17' ' ' PRO . . . 132.74 74.27 0.1 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.2 t -134.84 145.97 48.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -1.099 . . . . 0.0 110.191 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.482 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.475 ' O ' HD21 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.297 0.57 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 6.2 mp -89.35 -27.0 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 110.326 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 104.55 1.57 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.3 -160.66 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.537 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.537 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' LEU . 40.0 m95 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.7 OUTLIER -36.34 -66.39 0.22 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.693 0.759 . . . . 0.0 110.233 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.14 32.75 0.39 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p -156.95 -179.02 7.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -1.092 . . . . 0.0 109.733 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.513 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 31' ' ' PRO . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.564 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 9.0 m170 -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' HD22 ' A' ' 22' ' ' LEU . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.475 HD13 ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -70.54 -68.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 57.24 98.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p -157.08 -174.64 5.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -1.18 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 19' ' ' CYS . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.475 ' SG ' HD13 ' A' ' 2' ' ' LEU . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' O ' HD21 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 21' ' ' GLY . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 17.2 m-70 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.377 0.608 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 1' ' ' TRP . 12.3 mt -60.03 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.981 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 17' ' ' PRO . . . -168.89 -140.55 2.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -160.36 75.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 110.812 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' CG ' ' HA3' ' A' ' 3' ' ' GLY . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 31' ' ' PRO . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.314 0.578 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.74 140.02 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.9 -25.65 0.1 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.246 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.89 -176.5 5.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.023 -1.281 . . . . 0.0 110.733 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' PRO . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HA ' ' HB1' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 38.4 m-70 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.574 ' CH2' ' HD2' ' A' ' 6' ' ' ARG . 10.5 m95 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.317 0.58 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 57.0 tp -177.95 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.016 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.3 -43.88 89.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p -160.1 -170.85 2.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -1.153 . . . . 0.0 110.256 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 18' ' ' CYS . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.574 ' HD2' ' CH2' ' A' ' 1' ' ' TRP . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.578 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.578 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HA ' ' HB1' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.471 ' CB ' ' HB3' ' A' ' 18' ' ' CYS . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.8 m-70 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.413 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.47 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 4.8 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 0.2 OUTLIER 169.92 -52.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.332 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.68 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p -156.05 172.04 19.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -1.139 . . . . 0.0 109.995 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 18' ' ' CYS . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.46 ' O ' ' HB1' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CG ' ' CD2' ' A' ' 30' ' ' HIS . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.553 ' CD2' ' CG ' ' A' ' 25' ' ' ASP . 3.1 m-70 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HA ' HD23 ' A' ' 22' ' ' LEU . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mt -112.82 128.2 56.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.95 106.16 3.19 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p -159.24 173.15 16.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -1.185 . . . . 0.0 110.766 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.418 ' HG3' ' NH2' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' O ' ' HB1' ' A' ' 5' ' ' ALA . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 31.9 t-105 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.366 0.603 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 0.2 OUTLIER 173.15 -27.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.364 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.72 47.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p -160.01 -167.0 1.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -1.052 . . . . 0.0 109.587 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.565 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.497 ' SG ' ' CB ' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.65 128.49 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.209 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.64 -98.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.38 171.61 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -1.126 . . . . 0.0 110.018 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.427 ' HB1' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' CYS . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 7' ' ' VAL . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.54 ' HA ' ' CE3' ' A' ' 1' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.314 0.578 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.532 ' CD2' ' HG2' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -65.62 -88.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.72 73.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p -155.29 157.87 37.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.24 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.532 ' HG2' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 22' ' ' LEU . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.463 ' O ' HD22 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.574 ' O ' ' CE3' ' A' ' 1' ' ' TRP . 10.2 p-90 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.231 0.538 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 -41.88 29.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.35 -76.06 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p -153.61 159.08 42.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -1.138 . . . . 0.0 110.187 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.54 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 14.0 m-70 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' O ' ' C ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.327 0.584 . . . . 0.0 110.433 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.1 OUTLIER -33.75 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 0.0 111.236 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.27 102.56 2.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -104.39 -159.91 0.74 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.583 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD2' ' CB ' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.489 ' CB ' ' OD2' ' A' ' 25' ' ' ASP . 4.1 m170 -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.22 0.533 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.789 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HG2' HG23 ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 32' ' ' GLN . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.608 ' O ' HD23 ' A' ' 22' ' ' LEU . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.181 0.515 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.574 ' O ' HD23 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.538 ' CD1' ' C ' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.812 ' O ' HD23 ' A' ' 22' ' ' LEU . 50.9 m80 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.409 0.624 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.588 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.751 ' CD2' HG13 ' A' ' 7' ' ' VAL . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.418 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 13.9 m80 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 3.2 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.356 0.598 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 HD21 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.473 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' TRP . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.737 HD21 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.679 ' O ' HD23 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.528 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.531 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.189 0.519 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.489 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 30' ' ' HIS . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.318 0.58 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 29' ' ' CYS . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HB3' HD13 ' A' ' 22' ' ' LEU . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.4 m80 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 30' ' ' HIS . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.728 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.479 0.657 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CE3' ' CA ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 22.9 m80 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 9' ' ' GLU . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.135 HG22 HD21 ' A' ' 22' ' ' LEU . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.135 HD21 HG22 ' A' ' 7' ' ' VAL . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.1 m80 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.079 0.466 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 1.001 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.6 m80 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.43 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 7' ' ' VAL . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.603 ' NE2' ' OXT' ' A' ' 32' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.563 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.779 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.923 ' SG ' HD12 ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.923 HD12 ' SG ' ' A' ' 19' ' ' CYS . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.668 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HA ' HD23 ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HD12 ' A' ' 22' ' ' LEU . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 19' ' ' CYS . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.299 0.571 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 7' ' ' VAL . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.517 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.28 0.562 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 22' ' ' LEU . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.42 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.6 m80 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 7' ' ' VAL . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 22' ' ' LEU . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.762 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.527 ' OD2' ' CD2' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.527 ' CD2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m95 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.265 0.555 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.34 -58.21 1.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.01 -112.53 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p -151.52 175.01 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.789 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HG2' HG23 ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 32' ' ' GLN . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.608 ' O ' HD23 ' A' ' 22' ' ' LEU . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.231 0.539 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.52 124.07 35.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.94 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.59 6.1 5.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.21 -163.19 0.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 109.876 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.574 ' O ' HD23 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 3' ' ' GLY . 63.1 m95 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.357 0.599 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.0 mt 50.06 -93.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 1' ' ' TRP . . . -174.13 115.92 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p -149.43 145.77 27.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -1.168 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.783 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.538 ' CD1' ' C ' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.812 ' O ' HD23 ' A' ' 22' ' ' LEU . 50.9 m80 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.52 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.59 -18.15 0.88 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p -104.3 -152.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.251 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.588 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.751 ' CD2' HG13 ' A' ' 7' ' ' VAL . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.418 ' HB3' ' CE1' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 13.9 m80 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.267 0.556 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.2 mt -114.76 131.52 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 17' ' ' PRO . . . 132.74 74.27 0.1 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 3.2 t -134.84 145.97 48.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -1.099 . . . . 0.0 110.191 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 HD21 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.473 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.737 HD21 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.679 ' O ' HD23 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.297 0.57 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.2 mp -89.35 -27.0 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 110.326 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 104.55 1.57 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.3 -160.66 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.531 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' LEU . 40.0 m95 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.7 OUTLIER -36.34 -66.39 0.22 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.693 0.759 . . . . 0.0 110.233 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.14 32.75 0.39 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p -156.95 -179.02 7.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -1.092 . . . . 0.0 109.733 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.489 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 30' ' ' HIS . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -68.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 57.24 98.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p -157.08 -174.64 5.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -1.18 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 29' ' ' CYS . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HB3' HD13 ' A' ' 22' ' ' LEU . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.4 m80 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.377 0.608 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 1' ' ' TRP . 12.3 mt -60.03 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.981 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 17' ' ' PRO . . . -168.89 -140.55 2.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -160.36 75.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 110.812 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' CG ' ' HA3' ' A' ' 3' ' ' GLY . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 30' ' ' HIS . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.728 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.314 0.578 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 2' ' ' LEU . 6.8 tt -127.74 140.02 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.9 -25.65 0.1 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.246 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.89 -176.5 5.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.023 -1.281 . . . . 0.0 110.733 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CE3' ' CA ' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 22.9 m80 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.598 ' CH2' ' HD2' ' A' ' 6' ' ' ARG . 10.5 m95 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.317 0.58 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 57.0 tp -177.95 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.016 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.3 -43.88 89.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p -160.1 -170.85 2.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -1.153 . . . . 0.0 110.256 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 9' ' ' GLU . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HD2' ' CH2' ' A' ' 1' ' ' TRP . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.135 HG22 HD21 ' A' ' 22' ' ' LEU . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.135 HD21 HG22 ' A' ' 7' ' ' VAL . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.1 m80 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 4.8 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.844 HD22 ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER 169.92 -52.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.332 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.68 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p -156.05 172.04 19.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -1.139 . . . . 0.0 109.995 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.844 ' SG ' HD22 ' A' ' 2' ' ' LEU . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 1.001 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.6 m80 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.43 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mt -112.82 128.2 56.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.95 106.16 3.19 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p -159.24 173.15 16.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -1.185 . . . . 0.0 110.766 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 7' ' ' VAL . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.603 ' NE2' ' OXT' ' A' ' 32' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.432 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 31.9 t-105 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.366 0.603 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 1' ' ' TRP . 0.2 OUTLIER 173.15 -27.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.364 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.72 47.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p -160.01 -167.0 1.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -1.052 . . . . 0.0 109.587 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.563 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.779 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.923 ' SG ' HD12 ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.923 HD12 ' SG ' ' A' ' 19' ' ' CYS . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.668 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HA ' HD23 ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.65 128.49 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.209 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.64 -98.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.38 171.61 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -1.126 . . . . 0.0 110.018 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HD12 ' A' ' 22' ' ' LEU . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 19' ' ' CYS . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.487 ' HA ' ' CE3' ' A' ' 1' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.314 0.578 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -65.62 -88.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.72 73.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p -155.29 157.87 37.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.24 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.695 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 7' ' ' VAL . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.517 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.574 ' CE3' ' O ' ' A' ' 1' ' ' TRP . 10.2 p-90 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.231 0.538 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 -41.88 29.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.35 -76.06 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p -153.61 159.08 42.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -1.138 . . . . 0.0 110.187 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 22' ' ' LEU . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.42 ' O ' HD23 ' A' ' 22' ' ' LEU . 6.6 m80 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 7' ' ' VAL . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' O ' ' C ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.327 0.584 . . . . 0.0 110.433 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.1 OUTLIER -33.75 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 0.0 111.236 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.27 102.56 2.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -104.39 -159.91 0.74 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.583 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 22' ' ' LEU . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.762 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' OD2' ' CD2' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.527 ' CD2' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.22 0.533 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.789 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HG2' HG23 ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 32' ' ' GLN . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.608 ' O ' HD23 ' A' ' 22' ' ' LEU . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.181 0.515 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.574 ' O ' HD23 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.538 ' CD1' ' C ' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.812 ' O ' HD23 ' A' ' 22' ' ' LEU . 51.5 m-70 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.409 0.624 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.588 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.751 ' CD2' HG13 ' A' ' 7' ' ' VAL . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.595 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.595 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 20.3 m-70 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 3.2 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.356 0.598 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 HD21 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.473 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' TRP . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.737 HD21 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.679 ' O ' HD23 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.21 0.528 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.531 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.189 0.519 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.489 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 30' ' ' HIS . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 9.0 m170 -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.318 0.58 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 29' ' ' CYS . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HB3' HD13 ' A' ' 22' ' ' LEU . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 17.2 m-70 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 30' ' ' HIS . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.728 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.479 0.657 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 25' ' ' ASP . 38.4 m-70 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 9' ' ' GLU . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.135 HG22 HD21 ' A' ' 22' ' ' LEU . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.135 HD21 HG22 ' A' ' 7' ' ' VAL . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.8 m-70 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.079 0.466 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CG ' ' CD2' ' A' ' 30' ' ' HIS . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 1.001 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 m-70 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.43 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.356 0.598 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 7' ' ' VAL . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.563 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.779 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.923 ' SG ' HD12 ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.923 HD12 ' SG ' ' A' ' 19' ' ' CYS . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.668 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HA ' HD23 ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HD12 ' A' ' 22' ' ' LEU . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 19' ' ' CYS . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.299 0.571 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 7' ' ' VAL . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.517 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.28 0.562 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 22' ' ' LEU . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.54 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 14.0 m-70 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 7' ' ' VAL . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 22' ' ' LEU . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.762 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD2' ' CB ' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.489 ' CB ' ' OD2' ' A' ' 25' ' ' ASP . 4.1 m170 -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m95 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.265 0.555 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.34 -58.21 1.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.01 -112.53 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 p -151.52 175.01 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.789 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -65.9 175.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.262 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 6.3 mtt-85 -124.37 -164.56 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.02 -1.05 . . . . 0.0 110.6 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 8' ' ' LYS . 29.1 m -84.29 15.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.221 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HG2' HG23 ' A' ' 7' ' ' VAL . 26.7 mmtm -145.34 12.67 1.37 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 9' ' ' GLU . 2.6 tp10 -101.77 150.42 23.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.993 0.901 . . . . 0.0 110.227 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.34 119.0 21.77 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.268 0.556 . . . . 0.0 110.377 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 31.8 p -128.56 -168.5 1.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.33 -0.857 . . . . 0.0 110.286 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.02 -159.64 11.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.58 -52.74 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.072 1.564 . . . . 0.0 110.397 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CD1' ' N ' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -139.48 34.93 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.0 110.048 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -109.85 -31.9 7.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.831 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.83 109.38 3.52 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.524 -0.735 . . . . 0.0 109.752 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 115.28 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.96 1.506 . . . . 0.0 110.691 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -83.13 173.28 11.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 110.055 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 26.5 m -66.56 -170.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -90.36 114.38 26.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.84 -2.85 21.31 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 30' ' ' HIS . 64.3 mt -114.9 118.93 34.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -1.156 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 32' ' ' GLN . 9.0 pttp -112.98 133.99 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 110.064 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 97.4 m -54.14 101.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' CB ' ' ND1' ' A' ' 30' ' ' HIS . 20.2 t70 -85.32 59.61 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.201 -0.937 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.67 -53.59 0.6 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 -36.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -1.101 . . . . 0.0 110.369 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -105.86 123.77 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 110.345 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.0 OUTLIER -48.0 134.4 13.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.23 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.608 ' O ' HD23 ' A' ' 22' ' ' LEU . 16.0 m170 -114.83 165.55 13.71 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.14 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' A' ' 22' ' ' LEU . 50.6 Cg_endo -81.52 43.83 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.115 1.587 . . . . 0.0 110.72 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 14.5 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.231 0.539 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 mp -128.52 124.07 35.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.94 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.59 6.1 5.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.21 -163.19 0.98 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 109.876 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -69.02 168.02 14.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 1.2 mtt180 -121.15 170.37 9.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.463 -0.773 . . . . 0.0 110.015 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 62.0 t -57.59 -70.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.335 -0.853 . . . . 0.0 110.428 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 20.1 pttp -47.4 -18.41 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.45 -0.781 . . . . 0.0 111.531 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 9.0 tt0 -78.85 135.23 36.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.883 -1.135 . . . . 0.0 110.595 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.57 110.91 22.04 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.291 0.567 . . . . 0.0 110.818 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -116.71 -159.32 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.894 . . . . 0.0 110.402 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 120.18 -128.86 7.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.08 12.66 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.877 1.462 . . . . 0.0 110.542 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -115.73 -26.0 7.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.158 -0.964 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -149.2 -161.31 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.846 -1.159 . . . . 0.0 111.119 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.8 m95 -71.38 167.61 28.58 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.584 -0.697 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 43.2 Cg_endo -69.86 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.713 1.375 . . . . 0.0 110.726 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 58.6 m -104.65 162.57 13.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.49 -0.756 . . . . 0.0 110.448 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.8 m -48.5 172.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.301 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -65.43 128.66 36.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.934 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . 96.79 -5.04 63.82 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 30' ' ' HIS . 2.0 mt -121.51 149.24 43.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 109.893 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -152.81 128.51 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.937 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.56 113.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 1.7 t70 -91.19 22.5 3.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 110.458 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.43 -33.34 1.57 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -154.05 -78.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -1.19 . . . . 0.0 110.158 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 7.3 mt-10 -79.29 162.68 25.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -0.793 . . . . 0.0 109.948 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 51.3 m -74.78 110.0 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.574 ' O ' HD23 ' A' ' 22' ' ' LEU . 29.0 m-70 -87.95 154.49 52.57 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 110.406 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 32' ' ' GLN . 46.1 Cg_endo -72.05 85.24 1.02 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.058 1.557 . . . . 0.0 110.021 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 21' ' ' GLY . 4.2 tp60 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.634 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 3' ' ' GLY . 63.1 m95 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.357 0.599 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.0 mt 50.06 -93.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 1' ' ' TRP . . . -174.13 115.92 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.8 p -149.43 145.77 27.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -1.168 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -56.31 160.99 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 110.295 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -114.4 -163.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.277 -0.889 . . . . 0.0 110.235 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.783 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.9 p -86.55 57.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.276 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' C ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 172.2 32.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 110.439 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.07 123.45 20.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 110.219 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -54.67 104.66 0.12 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 0.7 OUTLIER -103.18 -159.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 110.479 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -171.19 157.26 27.88 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.66 -33.6 8.11 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.963 1.507 . . . . 0.0 110.415 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.538 ' C ' ' CD1' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -106.19 -3.1 21.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.848 . . . . 0.0 110.644 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 2.0 tp10 -108.14 -158.27 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.657 ' CD1' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -41.2 130.97 2.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.484 -0.76 . . . . 0.0 109.841 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.75 -173.35 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.874 1.46 . . . . 0.0 110.45 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 t -147.16 137.35 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.453 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -44.47 152.92 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.661 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 p -68.75 158.92 33.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -0.878 . . . . 0.0 110.282 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.52 -18.28 56.48 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -114.21 169.84 8.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.258 . . . . 0.0 110.447 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 22' ' ' LEU . 4.5 mttm -156.03 115.19 3.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 109.935 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 1.3 m -59.58 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -87.0 61.09 6.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.149 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.44 -59.4 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.39 -48.25 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -1.118 . . . . 0.0 110.442 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -92.46 151.13 20.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.394 -0.816 . . . . 0.0 110.751 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.1 m -69.1 110.26 4.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.303 -0.873 . . . . 0.0 110.145 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.812 ' O ' HD23 ' A' ' 22' ' ' LEU . 51.5 m-70 -86.55 166.87 25.32 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.216 -0.927 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 52.4 Cg_endo -77.16 8.39 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.043 1.549 . . . . 0.0 110.816 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.288 -179.276 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.23 0.538 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.34 124.52 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 110.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 151.59 -18.15 0.88 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 p -104.3 -152.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.251 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -136.99 137.04 39.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -90.34 170.47 10.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.501 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -41.86 -83.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.588 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 mmtm -36.95 -27.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -79.2 135.93 36.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.032 -1.043 . . . . 0.0 110.781 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . . . -90.55 133.9 34.75 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 110.526 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 16' ' ' TRP . 1.1 p -114.01 -162.4 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.445 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . -143.39 -157.53 7.2 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.16 -92.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.988 1.52 . . . . 0.0 110.224 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -87.72 0.03 56.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.95 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' A' ' 16' ' ' TRP . 11.7 tp10 -79.97 176.81 9.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.188 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.597 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -34.97 95.98 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 111.283 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' GLU . 47.4 Cg_endo -74.61 -169.54 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.931 1.49 . . . . 0.0 110.25 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 17.1 m -102.01 141.24 35.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.908 . . . . 0.0 110.061 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -41.68 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 110.377 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 t -59.57 120.4 9.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.381 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.57 -1.41 8.73 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.751 ' CD2' HG13 ' A' ' 7' ' ' VAL . 6.4 mt -118.72 165.96 13.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -1.2 . . . . 0.0 110.229 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -137.52 98.86 3.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 110.622 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -57.0 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.595 ' HB3' ' CD2' ' A' ' 30' ' ' HIS . 25.4 t0 -78.8 -96.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.979 -1.076 . . . . 0.0 110.48 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.89 -37.45 22.48 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.8 t -160.38 -53.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 110.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 10' ' ' ALA . 1.8 mt-10 -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.45 -0.782 . . . . 0.0 109.641 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 9.8 m -76.84 146.15 37.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.015 -1.053 . . . . 0.0 109.069 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.595 ' CD2' ' HB3' ' A' ' 25' ' ' ASP . 20.3 m-70 -105.7 165.27 13.4 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 120.828 -1.17 . . . . 0.0 110.91 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.66 43.6 1.57 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.142 1.601 . . . . 0.0 111.01 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.165 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.267 0.556 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.2 mt -114.76 131.52 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 17' ' ' PRO . . . 132.74 74.27 0.1 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 3.2 t -134.84 145.97 48.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -1.099 . . . . 0.0 110.191 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -101.27 -154.19 0.47 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.073 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 10.0 mtm-85 -150.95 146.45 26.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG13 HD21 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -44.03 -35.62 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.9 37.78 0.68 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -134.47 145.65 49.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.95 93.67 9.68 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.211 0.529 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -109.72 132.81 53.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.937 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.21 -79.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.65 -154.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.055 1.555 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.555 ' O ' ' CE3' ' A' ' 14' ' ' TRP . 39.8 p-90 -82.22 41.46 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 110.627 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 16' ' ' TRP . 7.6 pt-20 -91.0 -138.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.473 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 12.8 m95 -50.05 106.28 0.62 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.008 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 42.8 Cg_endo -70.14 124.45 10.94 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.104 1.581 . . . . 0.0 110.608 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -76.55 140.35 41.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 110.721 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.01 169.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.329 -0.857 . . . . 0.0 110.299 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -75.09 135.3 41.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 107.93 -4.84 34.15 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.737 HD21 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -120.81 160.69 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.929 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -157.78 112.74 2.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 110.25 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 13.5 m -57.04 103.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.941 . . . . 0.0 109.79 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' HB2' ' ND1' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -85.33 48.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 110.161 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.65 -50.26 0.76 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -160.13 -58.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -1.12 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 9' ' ' GLU . 41.3 mt-10 -79.72 150.37 30.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.368 -0.833 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 7' ' ' VAL . 1.2 m -69.82 118.92 13.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.679 ' O ' HD23 ' A' ' 22' ' ' LEU . 17.4 m170 -95.31 168.8 10.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 50.9 Cg_endo -81.53 45.01 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.089 1.573 . . . . 0.0 110.323 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 3.3 tp-100 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.177 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.297 0.57 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 2' ' ' LEU . 6.2 mp -89.35 -27.0 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.929 . . . . 0.0 110.326 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.98 104.55 1.57 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 p -146.3 -160.66 1.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -1.136 . . . . 0.0 110.094 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -82.16 -158.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 mtm-85 -153.2 -158.13 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 7' ' ' VAL . 16.0 m -91.09 64.62 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.55 -21.33 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.501 -0.75 . . . . 0.0 110.95 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.04 129.58 34.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.926 -1.109 . . . . 0.0 110.222 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -66.0 101.56 0.69 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.325 0.583 . . . . 0.0 110.757 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -114.12 142.56 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.377 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.45 -174.42 16.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.25 -55.08 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -90.99 15.94 10.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 110.157 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG2' ' N ' ' A' ' 16' ' ' TRP . 48.2 tt0 -112.33 -94.17 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.531 ' N ' ' HG2' ' A' ' 15' ' ' GLU . 27.1 t-105 -109.82 129.76 23.57 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.068 -1.02 . . . . 0.0 109.96 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 49.5 Cg_endo -73.48 -14.65 25.01 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.901 1.474 . . . . 0.0 110.966 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 17' ' ' PRO . 3.4 t 70.74 175.41 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.932 . . . . 0.0 110.166 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HB2' HD12 ' A' ' 22' ' ' LEU . 33.7 m -69.15 177.85 2.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 110.313 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -85.16 -33.72 22.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 110.228 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.6 7.0 63.0 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.781 HD12 ' HB2' ' A' ' 19' ' ' CYS . 3.2 mt -108.15 -177.32 3.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -1.091 . . . . 0.0 110.16 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.46 92.19 1.21 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 110.235 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 117.08 6.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 109.904 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.87 84.41 1.93 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.018 -1.051 . . . . 0.0 111.107 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.76 -72.59 0.48 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 9.2 p -161.39 -33.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.986 . . . . 0.0 110.389 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.79 131.01 55.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.6 m -44.55 110.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.51 -0.744 . . . . 0.0 110.339 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.61 128.54 39.52 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 0.0 109.962 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' O ' ' OXT' ' A' ' 32' ' ' GLN . 42.2 Cg_endo -68.05 156.62 65.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.82 1.432 . . . . 0.0 110.631 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' OXT' ' O ' ' A' ' 31' ' ' PRO . 15.1 pt20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.435 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' LEU . 40.0 m95 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.7 OUTLIER -36.34 -66.39 0.22 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.693 0.759 . . . . 0.0 110.233 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.14 32.75 0.39 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 p -156.95 -179.02 7.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -1.092 . . . . 0.0 109.733 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -74.92 131.44 40.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.04 -1.037 . . . . 0.0 110.084 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 7.2 mtt180 -80.13 -156.1 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.02 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p -89.12 -12.18 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.307 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.64 3.47 21.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.058 -1.026 . . . . 0.0 110.258 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' A' ' 5' ' ' ALA . 2.5 tt0 -80.26 139.46 36.67 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.096 0.95 . . . . 0.0 110.665 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -73.52 85.9 1.56 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.349 0.595 . . . . 0.0 110.437 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 25.6 p -96.26 176.31 6.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.87 -170.94 39.35 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 14' ' ' TRP . 48.6 Cg_endo -77.2 7.22 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.005 1.529 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CE2' ' HG2' ' A' ' 13' ' ' PRO . 3.0 m-90 -118.32 -0.67 11.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.077 -1.014 . . . . 0.0 110.246 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 -163.1 1.31 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.136 -0.978 . . . . 0.0 110.744 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.489 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.4 m95 -75.25 166.88 41.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.425 -0.797 . . . . 0.0 110.164 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 16' ' ' TRP . 44.5 Cg_endo -72.55 -158.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.956 1.503 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.5 t -120.37 165.69 14.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 110.364 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 72.2 m -59.63 -166.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.41 -0.806 . . . . 0.0 110.126 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.45 122.72 33.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.82 12.45 32.23 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 30' ' ' HIS . 31.4 mt -133.89 136.59 44.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -1.125 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -120.66 111.41 17.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 5.5 t -45.69 116.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.935 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 30' ' ' HIS . 56.5 t0 -83.63 17.56 2.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.038 -1.039 . . . . 0.0 110.615 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.22 -45.09 1.32 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.4 p -126.35 -53.95 1.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -1.112 . . . . 0.0 110.21 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -112.87 140.42 47.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 110.104 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.3 m -59.14 134.61 57.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.586 ' CG ' ' HB2' ' A' ' 25' ' ' ASP . 9.0 m170 -114.1 163.52 18.72 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.022 -1.049 . . . . 0.0 110.411 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.94 134.03 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.948 1.499 . . . . 0.0 110.248 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.394 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -68.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.304 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 57.24 98.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 p -157.08 -174.64 5.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -1.18 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -85.41 136.03 33.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.7 178.65 6.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 109.967 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' GLU . 48.7 t -49.88 -70.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.969 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 7' ' ' VAL . 24.2 mmmt -39.49 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.547 -0.72 . . . . 0.0 111.15 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.2 tp10 -78.03 135.16 37.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.071 -1.018 . . . . 0.0 110.102 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -88.87 107.41 18.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.23 0.538 . . . . 0.0 110.765 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -104.89 170.82 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.02 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.39 -168.91 40.35 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.32 -26.78 14.14 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.038 1.546 . . . . 0.0 110.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -128.99 29.03 5.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.273 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -135.42 -159.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 28.2 m-90 -56.96 149.78 42.63 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.2 Cg_endo -74.46 -159.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.076 1.566 . . . . 0.0 110.504 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 12.5 t -171.42 139.6 1.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -47.31 174.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.436 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 -8.11 57.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.179 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -96.67 12.63 66.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 29' ' ' CYS . 33.8 mt -124.59 175.68 7.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -160.47 105.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.853 . . . . 0.0 110.191 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -59.37 112.54 1.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -94.74 25.86 3.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.959 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.98 -39.96 0.72 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.06 -63.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 110.418 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' N ' ' CD ' ' A' ' 28' ' ' GLU . 3.1 mp0 -79.25 159.11 27.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.44 -0.788 . . . . 0.0 110.462 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' HB3' HD13 ' A' ' 22' ' ' LEU . 13.3 m -78.12 106.79 10.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 17.2 m-70 -79.83 139.1 53.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.101 -0.999 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 32' ' ' GLN . 44.1 Cg_endo -72.23 114.94 4.13 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 31' ' ' PRO . 3.2 tp60 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.197 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.461 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.377 0.608 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 1' ' ' TRP . 12.3 mt -60.03 -133.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.981 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 17' ' ' PRO . . . -168.89 -140.55 2.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HA ' ' N ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -160.36 75.63 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -1.212 . . . . 0.0 110.812 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -69.89 -145.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.625 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 12.4 mtt180 -132.41 -179.19 5.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 8' ' ' LYS . 9.4 t -90.0 51.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 164.49 37.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 3.9 mm-40 -132.44 130.76 40.98 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.888 0.852 . . . . 0.0 110.315 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -40.95 116.73 0.76 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 29.7 p -136.55 129.3 30.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 0.0 110.098 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA3' ' OE1' ' A' ' 15' ' ' GLU . . . -136.31 -172.81 12.72 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 -17.68 26.3 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.121 1.59 . . . . 0.0 110.546 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -139.45 43.52 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.111 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' OE1' ' HA3' ' A' ' 12' ' ' GLY . 2.1 mp0 -143.56 -84.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 110.127 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 8.9 m-90 -120.13 143.11 34.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' CG ' ' HA3' ' A' ' 3' ' ' GLY . 45.9 Cg_endo -72.78 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.176 1.619 . . . . 0.0 110.52 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 3.0 t -169.03 113.21 0.55 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.045 -1.035 . . . . 0.0 110.42 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' N ' ' HA ' ' A' ' 4' ' ' CYS . 67.2 m -39.84 155.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -0.848 . . . . 0.0 110.482 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 156.12 26.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.05 85.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 30' ' ' HIS . 9.3 mt -125.98 156.04 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 110.265 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 30' ' ' HIS . 14.8 tttt -141.67 115.82 9.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.979 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 76.5 m -58.78 124.19 18.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.994 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.78 7.0 9.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.45 -0.56 24.98 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -149.96 -52.08 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -1.176 . . . . 0.0 110.43 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -130.76 147.19 52.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.0 110.455 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 1.4 m -56.08 123.54 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.728 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.2 m170 -109.61 174.93 2.14 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.401 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 48.9 Cg_endo -79.51 150.71 22.13 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.838 1.441 . . . . 0.0 110.029 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.999 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.314 0.578 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' ' 2' ' ' LEU . 6.8 tt -127.74 140.02 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.9 -25.65 0.1 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.246 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.89 -176.5 5.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.023 -1.281 . . . . 0.0 110.733 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -112.56 153.89 26.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.466 -0.771 . . . . 0.0 109.58 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 3.2 mmt180 -99.84 -163.87 1.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 110.154 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 7' ' ' VAL . 8.2 p -85.79 56.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER 164.27 37.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.551 -0.718 . . . . 0.0 110.099 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -122.3 136.59 54.93 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.988 0.899 . . . . 0.0 110.522 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' GLU . . . -48.53 114.76 1.03 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.038 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 15' ' ' GLU . 15.0 p -150.81 173.11 14.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 110.311 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.14 -90.92 0.19 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.51 -93.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.035 1.545 . . . . 0.0 110.717 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.02 33.22 5.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.032 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 62.7 mm-40 -92.59 -177.6 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -43.0 131.96 3.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' ALA . 46.9 Cg_endo -72.9 146.68 42.6 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.935 1.492 . . . . 0.0 110.765 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.63 -159.07 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 110.488 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.57 147.4 29.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.449 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 22' ' ' LEU . . . 95.19 -0.44 63.98 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 21' ' ' GLY . 31.0 mt -135.57 130.77 35.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.162 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -126.73 115.45 19.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.79 105.62 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 110.303 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -89.47 61.8 5.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.77 -64.72 0.34 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 p -156.6 13.93 0.29 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.3 -1.118 . . . . 0.0 110.778 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' SER . 7.5 mt-10 -148.04 142.68 26.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.02 -1.05 . . . . 0.0 110.574 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.9 m -64.81 114.75 4.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 25' ' ' ASP . 38.4 m-70 -107.33 168.43 8.01 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 49.4 Cg_endo -74.78 97.65 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.959 1.505 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.598 ' CH2' ' HD2' ' A' ' 6' ' ' ARG . 10.5 m95 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.317 0.58 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 57.0 tp -177.95 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.016 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.3 -43.88 89.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 p -160.1 -170.85 2.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -1.153 . . . . 0.0 110.256 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 9' ' ' GLU . . . -102.3 130.36 48.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.97 . . . . 0.0 110.199 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.598 ' HD2' ' CH2' ' A' ' 1' ' ' TRP . 0.0 OUTLIER -84.57 -157.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.243 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.135 HG22 HD21 ' A' ' 22' ' ' LEU . 92.6 t -85.35 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 168.67 43.4 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.613 -0.679 . . . . 0.0 109.794 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 23.9 tp10 -131.57 145.51 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 110.143 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.5 83.1 0.16 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.335 0.588 . . . . 0.0 110.547 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.6 t -91.26 159.45 16.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.18 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . 172.94 -175.83 45.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.52 -20.14 23.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.959 1.505 . . . . 0.0 110.321 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -96.34 9.62 40.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.178 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.64 -151.51 0.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.432 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' ' HD2' ' A' ' 17' ' ' PRO . 5.2 t-105 -98.86 143.57 26.59 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.574 ' HD2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 Cg_endo -68.48 150.2 75.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.89 1.468 . . . . 0.0 110.796 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 83.7 m -55.24 166.44 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 110.515 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 16.3 m -69.49 -170.36 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 128.31 35.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.154 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.73 47.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.135 HD21 HG22 ' A' ' 7' ' ' VAL . 17.6 mt -106.4 175.19 5.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.1 . . . . 0.0 110.297 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.1 127.08 6.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -61.02 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.457 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 11.1 t70 -93.29 61.85 3.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 111.079 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.13 -65.49 0.37 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.23 -34.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.442 -1.034 . . . . 0.0 110.403 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -98.86 134.02 42.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.0 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 11' ' ' CYS . 2.3 m -56.07 101.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 110.146 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 25' ' ' ASP . 1.8 m-70 -87.65 142.32 32.66 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.19 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 22' ' ' LEU . 46.1 Cg_endo -72.5 90.01 0.81 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.006 1.529 . . . . 0.0 110.496 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OXT' ' HG2' ' A' ' 32' ' ' GLN . 13.9 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 4.8 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.844 HD22 ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER 169.92 -52.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.332 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.68 1.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 p -156.05 172.04 19.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -1.139 . . . . 0.0 109.995 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' PRO . . . -83.03 129.37 35.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.072 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -84.6 -161.32 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.337 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 7' ' ' VAL . 8.5 p -90.26 64.92 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 174.44 -21.73 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.61 -0.681 . . . . 0.0 110.948 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.23 137.62 37.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.94 -1.1 . . . . 0.0 110.101 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -63.69 114.3 3.91 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.336 0.589 . . . . 0.0 110.88 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 29' ' ' CYS . 7.6 p -112.55 -176.33 2.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.78 -176.21 37.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.28 -6.95 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.69 14.25 1.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.468 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -103.81 -70.46 0.76 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.341 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 91.9 m95 -157.43 159.44 30.84 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.065 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 47.4 Cg_endo -73.2 -160.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.102 1.58 . . . . 0.0 110.191 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' CYS . 2.0 t -162.95 132.76 4.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.225 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.844 ' SG ' HD22 ' A' ' 2' ' ' LEU . 1.0 OUTLIER -51.84 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 p -86.84 151.28 23.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.2 69.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 30' ' ' HIS . 1.3 mt -131.95 166.77 20.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 110.058 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HB3' ' OXT' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.87 117.76 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 110.403 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 11' ' ' CYS . 1.2 t -55.08 114.45 1.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.877 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CG ' ' CD2' ' A' ' 30' ' ' HIS . 8.3 p-10 -78.67 -7.98 58.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 110.134 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.32 -14.05 2.53 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -149.03 -55.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -1.226 . . . . 0.0 110.966 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.43 136.59 53.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 110.72 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -52.49 114.44 1.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 1.001 ' O ' HD23 ' A' ' 22' ' ' LEU . 3.1 m-70 -90.63 169.2 12.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.16 9.17 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.975 1.513 . . . . 0.0 110.74 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.43 ' OXT' ' HB3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.127 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mt -112.82 128.2 56.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.95 106.16 3.19 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.2 p -159.24 173.15 16.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -1.185 . . . . 0.0 110.766 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -66.87 137.21 56.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 110.443 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -89.79 -157.6 0.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -89.65 53.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.115 -0.991 . . . . 0.0 110.143 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 4.9 pttt 168.52 54.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.621 -0.674 . . . . 0.0 109.817 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -157.87 138.9 13.3 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.107 0.956 . . . . 0.0 110.723 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -44.97 125.15 4.92 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.509 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.7 p -125.85 176.85 6.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.4 158.88 9.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.42 -6.51 18.92 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.977 1.514 . . . . 0.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -130.09 5.57 4.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.948 . . . . 0.0 110.209 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -120.99 -63.4 1.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -152.23 131.33 6.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.787 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.26 163.57 37.36 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.887 1.467 . . . . 0.0 110.139 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -103.82 138.15 40.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.109 -0.995 . . . . 0.0 110.313 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 5' ' ' ALA . 97.6 m -54.9 -171.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 t -86.96 125.23 33.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 0.0 110.161 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.43 -9.54 55.92 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HB ' ' A' ' 7' ' ' VAL . 2.3 mt -115.69 143.84 44.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 6.9 ptmt -128.31 122.94 32.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -51.77 101.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 4.0 t70 -85.62 54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.948 . . . . 0.0 110.697 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.18 -65.89 0.25 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -149.32 8.81 0.72 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -1.204 . . . . 0.0 110.99 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -146.5 123.5 11.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 1.3 m -54.81 108.13 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 110.019 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 1.5 m-70 -97.78 162.92 20.7 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.548 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' C ' ' A' ' 32' ' ' GLN . 48.3 Cg_endo -74.33 90.22 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.131 1.595 . . . . 0.0 110.72 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.1 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.432 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 31.9 t-105 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.366 0.603 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 1' ' ' TRP . 0.2 OUTLIER 173.15 -27.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.364 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.72 47.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 4.3 p -160.01 -167.0 1.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.412 -1.052 . . . . 0.0 109.587 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.779 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.48 101.8 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.971 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 4' ' ' CYS . 7.7 mtm180 -79.81 -153.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 110.346 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 38.6 t -89.87 60.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER 175.41 33.64 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.55 -0.719 . . . . 0.0 110.017 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.63 130.74 49.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 110.364 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -64.88 97.07 0.21 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 31.4 p -110.82 90.97 3.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.138 -0.976 . . . . 0.0 109.943 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . -57.34 -156.74 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -26.69 20.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.085 1.571 . . . . 0.0 110.447 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.563 ' HA ' ' CE3' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -159.87 35.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' CA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.77 -73.38 0.35 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.423 -0.798 . . . . 0.0 109.645 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -117.09 145.32 35.47 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.497 -0.752 . . . . 0.0 109.933 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -70.95 100.41 0.96 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.019 1.536 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.779 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 8.5 t -61.4 166.88 3.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 110.352 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.923 ' SG ' HD12 ' A' ' 22' ' ' LEU . 67.5 m -53.17 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.052 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.26 -43.99 10.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 0.0 110.062 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.5 28.26 7.78 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.923 HD12 ' SG ' ' A' ' 19' ' ' CYS . 45.2 mt -132.0 140.81 49.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.281 -1.129 . . . . 0.0 110.884 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -120.99 -170.51 2.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.743 . . . . 0.0 109.176 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.59 102.15 7.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.018 -1.051 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -83.95 65.98 8.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.257 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.45 -69.32 0.21 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.7 p -157.53 11.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -1.119 . . . . 0.0 111.06 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -129.74 133.56 47.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.771 -1.206 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.668 ' SG ' ' HB1' ' A' ' 5' ' ' ALA . 1.3 m -63.64 95.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 2.7 m-70 -88.37 171.55 9.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 110.382 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HA ' HD23 ' A' ' 22' ' ' LEU . 47.9 Cg_endo -75.78 113.91 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.974 1.513 . . . . 0.0 110.282 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 33.0 mt-30 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.251 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.65 128.49 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.209 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.64 -98.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.38 171.61 12.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -1.126 . . . . 0.0 110.018 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . . . -84.09 112.12 19.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -79.93 -150.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.146 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 12.2 t -83.91 49.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 173.46 34.36 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.416 -0.803 . . . . 0.0 109.903 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -132.67 140.29 48.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.88 107.66 4.13 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.224 0.535 . . . . 0.0 110.41 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 22.2 p -85.06 -21.09 29.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.298 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 11' ' ' CYS . . . 54.17 169.64 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -19.8 22.16 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.997 1.525 . . . . 0.0 110.54 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -147.49 22.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.222 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -93.59 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.162 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' GLU . 77.7 m95 -41.72 141.54 1.22 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.63 129.41 12.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.992 1.522 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 19' ' ' CYS . 4.9 t -57.88 140.06 52.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' HD12 ' A' ' 22' ' ' LEU . 60.6 m -48.3 174.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.143 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.92 116.99 21.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.72 1.38 34.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 19' ' ' CYS . 19.6 mt -115.33 125.4 53.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 0.0 110.166 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -111.62 112.75 24.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.301 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 114.34 2.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.121 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.96 45.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.257 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.2 -53.74 0.78 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -157.59 -44.28 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 110.293 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -89.3 123.18 33.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 5' ' ' ALA . 1.7 m -50.57 125.55 13.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.346 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.76 174.61 2.31 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 110.08 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 30' ' ' HIS . 46.1 Cg_endo -73.02 140.22 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.994 1.523 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.487 ' HA ' ' CE3' ' A' ' 1' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.314 0.578 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -65.62 -88.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 70.64 15.72 73.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.6 p -155.29 157.87 37.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.091 -1.24 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -48.3 153.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.364 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.695 ' HG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -107.25 -166.99 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -0.911 . . . . 0.0 110.493 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 7' ' ' VAL . 60.3 t -90.32 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.791 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 7' ' ' VAL . 6.4 mtpt -178.33 -29.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.618 -0.677 . . . . 0.0 110.45 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -79.57 153.52 29.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.196 -0.94 . . . . 0.0 110.28 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' SER . . . -90.5 129.39 36.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.78 -0.575 . . . . 0.0 110.5 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -111.58 137.26 49.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.323 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.49 -167.5 24.61 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 -57.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.007 1.53 . . . . 0.0 110.598 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -105.63 44.1 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -0.846 . . . . 0.0 110.263 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -104.41 -88.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 0.0 110.508 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.75 142.48 17.26 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.318 -0.864 . . . . 0.0 109.994 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.03 133.35 21.32 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.559 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.9 t -78.62 156.38 29.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.835 . . . . 0.0 110.105 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 50.8 m -49.29 142.46 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.104 -0.997 . . . . 0.0 109.717 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -59.62 121.64 12.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.7 18.12 4.91 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 1.9 mt -136.87 172.28 13.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -1.167 . . . . 0.0 110.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.1 tmtm? -155.15 114.25 3.61 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.434 -0.791 . . . . 0.0 110.126 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.35 90.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.97 . . . . 0.0 109.473 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' LYS . 14.2 t0 -79.6 75.36 6.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.377 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.72 -60.5 0.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -160.62 -36.26 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.401 -1.058 . . . . 0.0 110.155 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -96.9 148.17 23.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.411 -0.806 . . . . 0.0 110.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 1.2 m -69.33 122.97 19.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.517 ' O ' HD23 ' A' ' 22' ' ' LEU . 2.0 m170 -115.72 170.48 5.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.34 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' GLN . 47.3 Cg_endo -75.03 151.56 39.54 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.919 1.484 . . . . 0.0 110.235 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 31' ' ' PRO . 18.7 tt0 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.334 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.574 ' O ' ' CE3' ' A' ' 1' ' ' TRP . 10.2 p-90 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.231 0.538 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 -41.88 29.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 110.278 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.35 -76.06 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.9 p -153.61 159.08 42.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -1.138 . . . . 0.0 110.187 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -63.72 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.173 -0.955 . . . . 0.0 110.086 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -83.6 -174.27 5.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.258 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.704 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 p -85.7 56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.188 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 5.5 ptmt -179.71 33.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.473 -0.767 . . . . 0.0 109.86 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.91 141.78 47.49 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.893 0.854 . . . . 0.0 110.134 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.6 115.56 7.33 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.618 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.2 157.73 40.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.977 . . . . 0.0 110.075 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.57 -149.71 10.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.11 -90.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.931 1.49 . . . . 0.0 110.359 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -84.58 -4.18 58.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -87.15 136.64 32.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.119 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 15' ' ' GLU . 5.3 m-90 49.2 89.58 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.82 105.12 1.74 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.901 1.474 . . . . 0.0 110.47 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.3 t -59.6 154.98 16.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.189 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' HD12 ' A' ' 22' ' ' LEU . 86.0 m -54.19 -176.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.316 -0.865 . . . . 0.0 110.371 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -84.79 140.26 31.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.99 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.91 12.26 64.15 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 31' ' ' PRO . 11.5 mt -129.06 140.98 51.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -1.104 . . . . 0.0 110.154 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -139.92 119.3 12.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 110.298 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.3 m -61.7 121.46 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.063 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' CD2' ' A' ' 30' ' ' HIS . 63.7 t0 -79.8 -72.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.57 -25.32 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.8 t -160.75 -63.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -1.129 . . . . 0.0 110.444 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -79.94 145.39 32.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -61.29 136.82 58.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.54 ' CD2' ' CB ' ' A' ' 25' ' ' ASP . 14.0 m-70 -109.94 131.87 21.72 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.148 -0.97 . . . . 0.0 110.295 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 7' ' ' VAL . 47.7 Cg_endo -75.32 79.34 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.93 1.49 . . . . 0.0 110.333 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.216 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' O ' ' C ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.327 0.584 . . . . 0.0 110.433 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' TRP . 0.1 OUTLIER -33.75 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 0.0 111.236 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.27 102.56 2.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -104.39 -159.91 0.74 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -1.121 . . . . 0.0 109.583 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . . . -117.91 121.36 40.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.977 -1.077 . . . . 0.0 110.973 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -83.15 -156.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 0.0 110.207 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG22 HD21 ' A' ' 22' ' ' LEU . 12.0 t -89.52 60.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER 173.05 35.22 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.89 158.35 44.53 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.833 0.825 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.57 110.51 18.76 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.386 0.613 . . . . 0.0 110.469 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 10.6 p -112.99 150.03 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.69 -137.81 3.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.13 -92.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.01 1.532 . . . . 0.0 110.684 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.64 11.03 28.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.309 -0.87 . . . . 0.0 110.289 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.78 -60.65 2.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.99 93.68 43.33 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.525 -0.735 . . . . 0.0 109.889 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.74 116.53 4.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.02 1.537 . . . . 0.0 110.586 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.762 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 1.6 t -56.48 171.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.279 -0.888 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.0 m -88.9 143.47 26.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.607 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -42.97 135.63 3.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 110.06 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.44 23.98 15.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 19' ' ' CYS . 5.7 mt -138.45 -176.8 4.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.134 . . . . 0.0 110.471 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -157.13 97.4 1.66 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.636 -0.665 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 9.0 t -54.0 97.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 110.258 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' OD2' ' CB ' ' A' ' 30' ' ' HIS . 62.0 m-20 -79.61 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' ASP . . . -41.73 -53.72 4.39 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 p -160.06 -39.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.88 130.57 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.0 109.919 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 1.2 m -52.4 129.23 27.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.489 ' CB ' ' OD2' ' A' ' 25' ' ' ASP . 4.1 m170 -115.2 153.36 47.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.569 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.05 132.06 20.57 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.848 1.447 . . . . 0.0 110.274 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.256 -179.995 . . . . . . . . 0 0 . 1 stop_ save_